Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 218 entries
View as:

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00051532 Org: User:
Start: 09/30/99 End: 05/31/04 Due: 05/31/05

Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT02664805 Org: User:
Start: 02/29/16 End: 10/31/16 Due: 10/31/17

An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT02627989 Org: User:
Start: 12/10/15 End: 01/17/17 Due: 01/17/18

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06311682 Org: User:
Start: 06/10/24 End: 04/28/28 Due: 04/28/29

LEO19123 Cream in the Treatment of Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT00404196 Org: User:
Start: 10/31/06 End: 03/31/07 Due: 03/31/08

Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01229098 Org: User:
Start: 10/31/10 End: 10/31/11 Due: 10/31/12

Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02219633 Org: User:
Start: 07/31/14 End: 01/31/15 Due: 01/31/16

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

Phase: N/A Priority: Normal
NCT ID: NCT02355639 Org: User:
Start: 01/31/15 End: 04/30/15 Due: 04/30/16

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03669757 Org: User:
Start: 09/27/18 End: 02/01/19 Due: 02/01/20

Topical Aprepitant in Prurigo Patients

Phase: N/A Priority: Normal
NCT ID: NCT01963793 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05958407 Org: User:
Start: 08/28/23 End: 03/22/27 Due: 03/22/28

A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products

Phase: N/A Priority: Normal
NCT ID: NCT00875277 Org: User:
Start: 04/30/09 End: 07/31/09 Due: 07/31/10

PSOREAL - Managing PSOriasis in the REAL World

Phase: N/A Priority: Normal
NCT ID: NCT02935582 Org: User:
Start: 01/31/17 End: 12/30/20 Due: 12/30/21

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01430533 Org: User:
Start: 09/30/11 End: 12/31/11 Due: 12/31/12

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT02533973 Org: User:
Start: 09/30/15 End: 03/06/18 Due: 03/06/19

Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT05486117 Org: User:
Start: 09/06/22 End: 11/22/22 Due: 11/22/23

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

Phase: N/A Priority: Normal
NCT ID: NCT02416258 Org: User:
Start: 04/30/15 End: 06/30/15 Due: 06/30/16

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT00617903 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00475605 Org: User:
Start: 05/25/05 End: 01/31/19 Due: 01/31/20

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Phase: N/A Priority: Normal
NCT ID: NCT03556592 Org: User:
Start: 08/13/18 End: 06/20/20 Due: 06/20/21

A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01347255 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Phase: N/A Priority: Normal
NCT ID: NCT03160885 Org: User:
Start: 06/12/17 End: 08/14/19 Due: 08/14/20

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT06004050 Org: User:
Start: 09/05/23 End: 09/18/25 Due: 09/18/26

The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo

Phase: N/A Priority: Normal
NCT ID: NCT00758862 Org: User:
Start: 12/31/08 End: 02/28/09 Due: 02/28/10

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT05332366 Org: User:
Start: 04/19/22 End: 05/22/23 Due: 05/22/24